The Consequences of Price Controls for Patients
2021 could be a bad year for patients in the United States. Lawmakers have resumed their fight to pass sweeping price...
2021 could be a bad year for patients in the United States. Lawmakers have resumed their fight to pass sweeping price...
January 29, 2020 Arlington, VA – Today, CASE Vice President Gerard Scimeca issued the following statement upon the signing of...
Gerard Scimeca – Chairman, CASE January 7, 2020 Addressing sky-high healthcare costs is a pressing need in our country,...
December 23, 2019 In what could have been the policy hallmark of his first term in office, President Trump originally...
December 11, 2019 In what could be the policy hallmark of his first term in office, President Trump has...
December 4, 2019 A new report issued this week by the President’s Council of Economic Advisers (CEA) provides a startling snapshot of...
“I don’t think people would be supportive of this idea if they realized there would be so many fewer cures.”...
This month, millions of seniors will take advantage of the Medicare open enrollment period, shopping for Medicare Advantage and Medicare...
Yesterday, the House Energy and Commerce Committee debated the merits of H.R.3, a proposal released by Speaker of the House...
September 19, 2019 (Arlington, Virginia) — Today, CASE Vice President Gerard Scimeca issued a statement, condemning Speaker of the...
.@POTUS’ IRA is driving up Part D premiums for millions of Medicare beneficiaries, yet Dems like @SenSanders continue to help tout this disastrous legislation. The Biden-Harris @WhiteHouse is misleading the public on their policy’s real impact.
Two weeks from election day, the supposedly independent @FCC is proposing price regulation of #broadband by restricting what data plans companies can offer.
By prohibiting usage-based plans, the FCC would end up increasing prices FOR EVERYONE, including low-data users!
CASE Letter Urges FDA & FTC to Scrutinize Deal Between L’Oréal and Galderma -- "Both companies are currently under investigation or facing sizable lawsuits from claims that they have used harmful chemicals in their products."
https://caseforconsumers.org/2024/10/21/case-letter-urges-fda-ftc-to-scrutinize-deal-between-loreal-and-galderma/